drugset / Trial / NCT03428464

Bicarbonate Administration in Kidney Transplant Recipients

NCT03428464

Completed 20 enrolled University of Colorado, Denver
RandomizedCrossoverQuadruple-blindTreatment

Summary

Metabolic acidosis is associated with vascular endothelial dysfunction and is a common complication in patients who have received a kidney transplant. Kidney transplant recipients (KTR) with lower serum bicarbonate levels, even within the normal range, have an increased risk of graft loss and mortality. The investigators propose a prospective, double-blind, randomized, placebo-controlled, 18-week crossover pilot study to examine the effects of sodium bicarbonate on vascular endothelial function, graft function, and cognitive function in 20 KTR patients.

Timeline

Start
2018-12-05
Primary completion
2020-03-25
Completion
2020-03-25

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium bicarbonate Diagnostic / imaging agent 0.5 meq Oral

Indications